Abzena
https://abzena.comCambridge, CB22 3AT
United Kingdom of Great Britain and Northern Ireland (the)
Categories
- Active Pharmaceutical Ingredients (APIs)
- Active Pharmaceutical Ingredients (API) Analytical Services
- Antibody Drug Conjugates (ADCs)
- Biologics Supplier
- Bispecific Antibody Drug Conjugate (BsABCs)
- Contract Research Organization CRO
- Fill-Finish and Formulation
- Highly Potent Active Pharmaceutical Ingredient (HPAPI)
- Lipid Nanoparticles Formulation Supplier
- Monoclonal Antibody (MABs)
- Oligonucleotide Supplier
- Peptides
- RadioPharma Supplier
- Small Molecule Services Supplier
About Abzena:
Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of th...eir molecule and move medicines forward faster. The company has research, development, and cGMP facilities located in San Diego, CA; Bristol, PA; and Cambridge, UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors.
Service Offerings:
- Antibody discovery & Design
- Candidate screening/selection
- Immunogenicity assessments & MAPPs
- Antibody & Protein Engineering
- Bioconjugation & Complex Chemistry to produce antibody-drug conjugates (ADCs
- AOCs
- RDCs
- Lead Optimization
- Custom-synthesis of cytotoxic payloads/Reagents/Other small molecules
- Design of linker-payloads
- Mammalian Cell Line Development from DNA to Research Cell Banks (RCB)
- Upstream process development
- Small-scall non-GMP material production
- Analytics & Bioassays
- GMP cell-based potency assays
- formulation development
- analytical method developent
Reviews:
Send Message:
Send us a direct message for any enquiries or to request for a proposal.